Cite
HARVARD Citation
Duclos, F. et al. (2017). Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. MedChemComm. 8 (11), pp. 2093-2099. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Duclos, F. et al. (2017). Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. MedChemComm. 8 (11), pp. 2093-2099. [Online].